Fasting plasma glucose, lipid ratios, and atherogenic coefficient are the risk factors for hypertension in chronic kidney disease patients on hemodialysis: A report from the Regional High Speciality Hospital of Peninsular Yucatan, Mexico

Sudip Datta Banik; Ricardo  Hernández Cardoza; Rosa María Méndez González; Ana Ligia Gutiérrez Solis

doi:10.2478/anre-2020-0019

Authors

Sudip Datta Banik Center for Research and Advanced Studies (Cinvestav-IPN), Merida, Yucatan
Ricardo Hernández Cardoza Regional High Speciality Hospital of the Yucatan Peninsula, Merida, Yucatan
Rosa María Méndez González Center for Research and Advanced Studies (Cinvestav-IPN), Merida, Yucatan
Ana Ligia Gutiérrez Solis Regional High Speciality Hospital of the Yucatan Peninsula, Merida, Yucatan

DOI:

https://doi.org/10.2478/anre-2020-0019

Keywords:

lipid profile, cholesterol, triglycerides, hypertension

Abstract

Chronic kidney disease (CKD) is associated with the development of cardivascular disease (CVD). CKD is one of the major public health problems in Mexico. Derived parameters of lipid profile, namely atherogenic index of plasma (AIP), atherogenic coefficient (AC), and Castelli risk index (CRI I and CRI II) are useful for predicting hypertension among CKD patients on hemodialysis that are not widely reported from Mexico. Objective of the present study was to find interrelationships among blood pressure, fasting plasma glucose (FPG), and derived parameters of lipid profile (AIP, AC, CRI-I, and CRI-II) among adult CKD patients on hemodialysis in a hospital in Yucatan, Mexico. Methods: An observational study was performed using the medical records (2016 and 2017) of 47 CKD patients on hemodialysis in the Regional High Speciality Hospital of Yucatan Peninsula (HRAEPY in Spanish acronym). Multiple linear regression models were developed to evaluate the use of FPG level and derived parameters of lipid profile (AC, CRI-I, and CRI-II) as risk factors predicting mean arterial pressure (MAP). Results showed remarkable prevalence of excess weight (55% overweight, 15% obesity) and hypertension (64%) in the sample. Correlation coeffcients and multiple linear regression models showed significant rise of blood pressure in association with elevated FPG level and derived lipid profile parameters. The results confirm the use of FPG, AC, CRI-I and CRI-II as the indicators for an early diagnosis of hypertension and related CVDs among CKD patients on hemodialysis.

Downloads

Download data is not yet available.

References

Alam S, Siddiqui MR. 2014. Accelerated atherosclerosis in patients with Chronic Kidney Disease-the role of traditional and non-traditional risk factors. WebmedCentral 5(11):1–14.
View in Google Scholar

Amato D, Alvarez-Aguilar C, Castaneda-Lim-ones R, Rodriguez E, Avila-Diaz M, Arreola F. et al. 2005. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int 68:S11–S17.
View in Google Scholar

Bener A, Zirie M, Daghash MH, Al-Hamaq AO, Daradkeh G, Rikabi A. 2007. Lipids, lipoprotein (a) profile and HbA1c among Arabian Type 2 diabetic patients. Biomed Res 18(2):97–102.
View in Google Scholar

Benz K, Hilgers KF, Daniel C, Amann K. 2018. Vascular calcification in chronic kidney disease: the role of inflammation. Int J Nephrol Article ID 4310379, 7 pages.
View in Google Scholar

Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T. et al. 2019. An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients. Expert Opin Ther Targets 23(7):619–30.
View in Google Scholar

Bhardwaj S, Bhattacharjee J, Bhatnagar M, Tyagi S. 2013. Atherogenic index of plasma, castelli risk index and atherogenic coefficient-new parameters in assessing cardiovascular risk. Int J Pharm Biol Sci 3(3):359–64.
View in Google Scholar

Bo MS, Cheah WL, Lwin S, Moe Nwe T, Win TT, Aung M. 2018. Understanding the relationship between atherogenic index of plasma and cardiovascular disease risk factors among staff of an University in Malaysia. J Nutr Metab Article ID 7027624, 6 pages.
View in Google Scholar

Bucharles SGE, Wallbach KK, Moraes TPD, Pecoits-Filho R. 2019. Hypertension in patients on dialysis: diagnosis, mechanisms, and management. J Bras Nefrol 41(3):400–11.
View in Google Scholar

Carracedo J, Alique M, Vida C, Bodega G, Ceprián N, Morales E. 2020. Mechanisms of cardiovascular disorders in patients with chronic kidney disease: A process related to accelerated senescence. Front Cell Dev Biol 8, 185 (14 pages).
View in Google Scholar

Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN. et al. 2008. Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52(1):29–38.
View in Google Scholar

Ene-Iordache B, Perico N, Bikbov B, Carminati S, Remuzzi A, Perna A. et al. 2016. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study. Lancet Glob 4(5):e307–e319.
View in Google Scholar

Ferrannini E, Haffner S, Mitchell B, Stern M. 1991. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34(6):416–22.
View in Google Scholar

Fleming GM. 2011. Renal replacement therapy review. Past present and future. Organ-ogenesis 7(1): 2–12.
View in Google Scholar

González-Chávez A, Amancio-Chassin O, Islas-Andrade S, Revilla-Monsalve C, Hernández, M., Lara-Esqueda, A. et al. 2008. Factores de riesgo cardiovascular asociados a obesidad abdominal en adultos aparentemente sanos. Rev Med Inst Mex Seguro Soc 46(3):273–9.
View in Google Scholar

Hernández M, Rivera J, Shamah T, Cuevas L, Gómez L, Gaona E. et al. 2016. Encuesta Nacional de Salud y Nutrición de Medio Camino 2016. Mexico, Cuernavaca: Instituto Nacional de Salud Pública.
View in Google Scholar

Hoogeveen EK, Halbesma N, Rothman KJ, Stijnen T, van Dijk S, Dekker FW. et al. 2012. Obesity and mortality risk among younger dialysis patients. Clin J Am Soc Nephrol 7(2):280–8.
View in Google Scholar

Kamoru AA, Japhet OM, Adetunji AD, Musa MA, Hammed OO, Akinlawon AA. et al. 2017. Castelli Risk Index, Atherogenic Index of Plasma, and Atherogenic Coefficient: Emerging Risk Predictors of Cardiovascular Disease in HIV-Treated Patients. Saudi J Med Pharm Sci 4929:1101–10.
View in Google Scholar

Koleva DI, Andreeva-Gateva PA, Orbetzova M, Atanassova I, Nikolova J. 2015. Atherogenic index of plasma, castelli risk indexes and leptin/adiponectin ratio in women with metabolic syndrome. IJPMR 3(5):12–6.
View in Google Scholar

Lee, MJ, Park JT, Han SH, Kim YL, Kim YS, Yang CW. et al. 2017. The atherogenic index of plasma and the risk of mortality in incident dialysis patients: Results from a nationwide prospective cohort in Korea. PloS ONE12(5):e0177499.
View in Google Scholar

Luyckx VA, Tonelli M, Stanifer JW. 2018. The global burden of kidney disease and the sustainable development goals. B World Health Organ 96(6):414–22D.
View in Google Scholar

Moe SM, Chen NX. 2004. Pathophysiology of vascular calcification in chronic kidney disease. Circ Res 95(6):560–7.
View in Google Scholar

Nimmanapalli HD, Kasi AD, Devapatla P, Nuttakki V. 2016. Lipid ratios, atherogenic coefficient and atherogenic index of plasma as parameters in assessing cardiovascular risk in type 2 diabetes mellitus. Int J Res Med Sci 4(7):2863–9.
View in Google Scholar

Ninomiya T, Kiyohara Y, Kubo M, Tanizaki Y, Doi Y, Okubo K. et al. 2005. Chronic kidney disease and cardiovascular disease in a general Japanese population: the Hisayama Study. Kidney Int 68(1):228–36.
View in Google Scholar

Oguntola SO, Hassan MO, Duarte R, Dix-Peek T, Dickens C, Olorunfemi G. et al. 2018. Atherosclerotic vascular disease and its correlates in stable black South African kidney transplant recipients. Int J Nephrol Renovasc Dis 11:187–93.
View in Google Scholar

Onat A, Can G, Kaya H, Hergenc G. 2010. “Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol 4(2):89–98.
View in Google Scholar

Safar ME, Boudier HS. 2005. Vascular development, pulse pressure, and the mechanisms of hypertension. Hypertension 46(1):205–9.
View in Google Scholar

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL. et al. 2003. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108(17):2154–69.
View in Google Scholar

Stenvinkel P, Pecoits-Filho R, Lindholm B. 2003. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. Clin J Am Soc Nephrol 14(7):1927–39.
View in Google Scholar

Webster AC, Nagler EV, Morton RL, Masson P. 2017. Chronic kidney disease. Lancet 389(10075):1238–52.
View in Google Scholar

WHO. 1995. Physical status: The use of and interpretation of anthropometry, Report of a WHO Expert Committee.
View in Google Scholar

Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F. et al. 2004. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–52.
View in Google Scholar

Zhu X, Yu L, Zhou H, Ma Q, Zhou X, Lei T. et al. 2018. Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China. Lipids Health Dis 17:37 (6 pages).
View in Google Scholar